Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial.
Nat Med. 2023 Dec;29(12):3127-3136. doi: 10.1038/s41591-023-02635-7. Epub 2023 Nov 13.
Nat Med. 2023.
PMID: 37957373
Free PMC article.
Clinical Trial.
Comparison of pharmacokinetics, safety and tolerability of secukinumab administered subcutaneously using different delivery systems in healthy volunteers and in psoriasis patients.
Bruin G, Hockey HP, La Stella P, Sigurgeirsson B, Fu R, Patekar M, Charef P, Woessner R, Boutouyrie-Dumont B.
Bruin G, et al. Among authors: la stella p.
Br J Clin Pharmacol. 2020 Feb;86(2):338-351. doi: 10.1111/bcp.14155. Epub 2020 Jan 7.
Br J Clin Pharmacol. 2020.
PMID: 31658377
Free PMC article.
Item in Clipboard
Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension.
Giles TD, Bakris G, Oparil S, Weber MA, Li H, Mallick M, Bharucha DB, Chen C, Ferguson WG; NAC-MD-01 Substudy Investigators.
Giles TD, et al.
J Am Soc Hypertens. 2015 Nov;9(11):845-54. doi: 10.1016/j.jash.2015.08.003. Epub 2015 Aug 12.
J Am Soc Hypertens. 2015.
PMID: 26362831
Free article.
Clinical Trial.
Item in Clipboard
Cumulative irritation, sensitizing potential, phototoxicity and photoallergy of ozenoxacin in healthy adult volunteers.
Gropper S, Cepero AL, Dosik JS, LaStella P, Siemetzki H, Wigger-Alberti W.
Gropper S, et al.
Future Microbiol. 2014;9(8 Suppl):S23-31. doi: 10.2217/fmb.14.84.
Future Microbiol. 2014.
PMID: 25209521
Clinical Trial.
Item in Clipboard
Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, Pattathil M; NAC-MD-01 Study Investigators.
Giles TD, et al.
Lancet. 2014 May 31;383(9932):1889-98. doi: 10.1016/S0140-6736(14)60614-0.
Lancet. 2014.
PMID: 24881993
Clinical Trial.
Item in Clipboard
A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy.
Bodoky G, Timcheva C, Spigel DR, La Stella PJ, Ciuleanu TE, Pover G, Tebbutt NC.
Bodoky G, et al. Among authors: la stella pj.
Invest New Drugs. 2012 Jun;30(3):1216-23. doi: 10.1007/s10637-011-9687-4. Epub 2011 May 19.
Invest New Drugs. 2012.
PMID: 21594619
Clinical Trial.
Item in Clipboard
Cite
Cite